Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionprotein kinase activity

PRKD3 PASK CCND1 LRRK1 LYN EGFR

1.54e-04600286GO:0004672
GeneOntologyMolecularFunctionphosphatidylinositol 3-kinase regulator activity

ATG14 LYN

2.86e-0418282GO:0035014
GeneOntologyMolecularFunctionphosphotransferase activity, alcohol group as acceptor

PRKD3 PASK CCND1 LRRK1 LYN EGFR

3.79e-04709286GO:0016773
GeneOntologyMolecularFunctionkinase activity

PRKD3 PASK CCND1 LRRK1 LYN EGFR

5.63e-04764286GO:0016301
GeneOntologyMolecularFunctionkinase regulator activity

ATG14 CCND1 LYN EGFR

8.18e-04305284GO:0019207
GeneOntologyBiologicalProcesscellular response to estradiol stimulus

SSTR2 EGFR AIFM1

1.88e-0537293GO:0071392
GeneOntologyCellularComponentU2-type catalytic step 1 spliceosome

PRPF8 SNRNP200

1.56e-0414282GO:0071006
GeneOntologyCellularComponentcatalytic step 1 spliceosome

PRPF8 SNRNP200

1.56e-0414282GO:0071012
GeneOntologyCellularComponentpigment granule membrane

TPCN2 RAB27A

3.93e-0422282GO:0090741
GeneOntologyCellularComponentchitosome

TPCN2 RAB27A

3.93e-0422282GO:0045009
GeneOntologyCellularComponentmelanosome membrane

TPCN2 RAB27A

3.93e-0422282GO:0033162
GeneOntologyCellularComponentU5 snRNP

PRPF8 SNRNP200

5.09e-0425282GO:0005682
GeneOntologyCellularComponentU4/U6 x U5 tri-snRNP complex

PRPF8 SNRNP200

1.80e-0347282GO:0046540
GeneOntologyCellularComponentspliceosomal tri-snRNP complex

PRPF8 SNRNP200

1.88e-0348282GO:0097526
GeneOntologyCellularComponentU2-type precatalytic spliceosome

PRPF8 SNRNP200

2.12e-0351282GO:0071005
GeneOntologyCellularComponentprecatalytic spliceosome

PRPF8 SNRNP200

2.37e-0354282GO:0071011
GeneOntologyCellularComponentpostsynaptic specialization, intracellular component

DLGAP2 LYN

2.55e-0356282GO:0099091
DomainPROTEIN_KINASE_ATP

PRKD3 PASK LRRK1 LYN EGFR

6.40e-04459295PS00107
DomainProt_kinase_dom

PRKD3 PASK LRRK1 LYN EGFR

8.51e-04489295IPR000719
DomainPROTEIN_KINASE_DOM

PRKD3 PASK LRRK1 LYN EGFR

8.83e-04493295PS50011
DomainKinase-like_dom

PRKD3 PASK LRRK1 LYN EGFR

1.35e-03542295IPR011009
DomainProtein_kinase_ATP_BS

PRKD3 PASK LYN EGFR

2.65e-03379294IPR017441
DomainRNaseH-like_dom

ERI2 PRPF8

5.12e-0369292IPR012337
DomainTyrKc

LYN EGFR

8.20e-0388292SM00219
DomainTyr_kinase_cat_dom

LYN EGFR

8.20e-0388292IPR020635
DomainPROTEIN_KINASE_TYR

LYN EGFR

9.89e-0397292PS00109
DomainTyr_kinase_AS

LYN EGFR

9.89e-0397292IPR008266
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY

CCND1 EGFR

1.90e-0414212M47383
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY

CCND1 EGFR

2.19e-0415212M47375
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY

CCND1 EGFR

2.19e-0415212M47382
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY

CCND1 EGFR

2.50e-0416212M47363
Pubmed

Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma.

CCND1 EGFR

6.71e-07229228741068
Pubmed

Nuclear localization of epidermal growth factor receptor (EGFR) in ameloblastomas.

CCND1 EGFR

6.71e-07229225991665
Pubmed

Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification.

CCND1 EGFR

6.71e-07229222050898
Pubmed

Variability in clinical phenotypes of PRPF8-linked autosomal dominant retinitis pigmentosa correlates with differential PRPF8/SNRNP200 interactions.

PRPF8 SNRNP200

6.71e-07229229087248
Pubmed

CCND1 messenger RNA expression is correlated with EGFR mutation status in lung cancer.

CCND1 EGFR

6.71e-07229217922974
Pubmed

Selected proliferation markers correlated with dynamics of growth in colorectal cancer.

CCND1 EGFR

6.71e-07229229688906
Pubmed

EGFR-dependent phosphorylation of leucine-rich repeat kinase LRRK1 is important for proper endosomal trafficking of EGFR.

LRRK1 EGFR

6.71e-07229222337768
Pubmed

PRPF8-mediated dysregulation of hBrr2 helicase disrupts human spliceosome kinetics and 5´-splice-site selection causing tissue-specific defects.

PRPF8 SNRNP200

6.71e-07229238605034
Pubmed

The inactive C-terminal cassette of the dual-cassette RNA helicase BRR2 both stimulates and inhibits the activity of the N-terminal helicase unit.

PRPF8 SNRNP200

6.71e-07229231914407
Pubmed

Inhibition of RNA helicase Brr2 by the C-terminal tail of the spliceosomal protein Prp8.

PRPF8 SNRNP200

6.71e-07229223704370
Pubmed

Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification.

CCND1 EGFR

2.01e-06329219525979
Pubmed

Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells.

CCND1 EGFR

2.01e-06329224499623
Pubmed

Mutation Analysis of Pre-mRNA Splicing Genes PRPF31, PRPF8, and SNRNP200 in Chinese Families with Autosomal Dominant Retinitis Pigmentosa.

PRPF8 SNRNP200

2.01e-06329230360737
Pubmed

NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR.

CCND1 EGFR

2.01e-06329224143218
Pubmed

Recurrent copy number alterations involving EGFR, CDKN2A, and CCND1 in oral premalignant lesions.

CCND1 EGFR

2.01e-06329235488777
Pubmed

Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination.

LIFR EGFR

2.01e-06329215385618
Pubmed

Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.

CCND1 EGFR

2.01e-06329218067636
Pubmed

Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1.

CCND1 EGFR

2.01e-06329222581837
Pubmed

Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.

CCND1 EGFR

2.01e-06329215791567
Pubmed

TIP30 nuclear translocation negatively regulates EGF-dependent cyclin D1 transcription in human lung adenocarcinoma.

CCND1 EGFR

2.01e-06329225135222
Pubmed

Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor.

LYN EGFR

2.01e-06329222430206
Pubmed

Epidermal Growth Factor Induces Proliferation of Hair Follicle-Derived Mesenchymal Stem Cells Through Epidermal Growth Factor Receptor-Mediated Activation of ERK and AKT Signaling Pathways Associated with Upregulation of Cyclin D1 and Downregulation of p16.

CCND1 EGFR

2.01e-06329227702388
Pubmed

Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study).

CCND1 EGFR

2.01e-06329221036743
Pubmed

Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis.

CCND1 EGFR

2.01e-06329220373052
Pubmed

Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer.

CCND1 EGFR

2.01e-06329220092659
Pubmed

EGFR-mediated Akt and MAPKs signal pathways play a crucial role in patulin-induced cell proliferation in primary murine keratinocytes via modulation of Cyclin D1 and COX-2 expression.

CCND1 EGFR

2.01e-06329223813870
Pubmed

EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer.

LIFR EGFR

2.01e-06329232963351
Pubmed

Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro.

CCND1 SSTR2

2.01e-06329216601140
Pubmed

FIH-1 disrupts an LRRK1/EGFR complex to positively regulate keratinocyte migration.

LRRK1 EGFR

2.01e-06329225455687
Pubmed

Structure of a multipartite protein-protein interaction domain in splicing factor prp8 and its link to retinitis pigmentosa.

PRPF8 SNRNP200

2.01e-06329217317632
Pubmed

Amplification of CCND1, EMS1, PIK3CA, and ERBB oncogenes in ethmoid sinus adenocarcinomas.

CCND1 EGFR

4.02e-06429216815198
Pubmed

Effects of CD73 on human colorectal cancer cell growth in vivo and in vitro.

CCND1 EGFR

4.02e-06429226708311
Pubmed

Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.

CCND1 EGFR

4.02e-06429220586028
Pubmed

EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.

CCND1 EGFR

4.02e-06429212825853
Pubmed

Transcriptional activation of cyclin D1 via HER2/HER3 contributes to EGFR-TKI resistance in lung cancer.

CCND1 EGFR

4.02e-06429232535106
Pubmed

Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region.

CCND1 EGFR

4.02e-06429212607604
Pubmed

LRRK1-phosphorylated CLIP-170 regulates EGFR trafficking by recruiting p150Glued to microtubule plus ends.

LRRK1 EGFR

4.02e-06429225413345
Pubmed

The EGF receptor is required for efficient liver regeneration.

CCND1 EGFR

4.02e-06429217940036
Pubmed

Structure and Conformational Dynamics of the Human Spliceosomal Bact Complex.

PRPF8 SNRNP200

4.02e-06429229361316
Pubmed

cbl-3: a new mammalian cbl family protein.

LYN EGFR

4.02e-06429210362357
Pubmed

UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes.

CCND1 EGFR

4.02e-06429218483258
Pubmed

Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium.

CCND1 EGFR

4.02e-06429223463347
Pubmed

Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer.

CCND1 EGFR

6.70e-06529217912028
Pubmed

Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours.

CCND1 EGFR

6.70e-06529220662834
Pubmed

The human U5-220kD protein (hPrp8) forms a stable RNA-free complex with several U5-specific proteins, including an RNA unwindase, a homologue of ribosomal elongation factor EF-2, and a novel WD-40 protein.

PRPF8 SNRNP200

6.70e-0652929774689
Pubmed

Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer.

CCND1 EGFR

6.70e-06529218349392
Pubmed

Src-mediated RGS16 tyrosine phosphorylation promotes RGS16 stability.

LYN EGFR

6.70e-06529212588871
Pubmed

Candidate gene polymorphisms for diabetes mellitus, cardiovascular disease and cancer are associated with longevity in Koreans.

LYN EGFR

6.70e-06529219641380
Pubmed

Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients.

CCND1 EGFR

6.70e-06529220631637
Pubmed

Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases.

LYN EGFR

6.70e-06529216687414
Pubmed

The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III.

ATG14 EGFR

6.70e-06529229587298
Pubmed

Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.

LIFR PRPF8 EGFR AIFM1 SNRNP200 RAB27A

9.84e-0661329622268729
Pubmed

Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.

CCND1 EGFR

1.00e-05629224145651
Pubmed

The human homologue of the yeast splicing factor prp6p contains multiple TPR elements and is stably associated with the U5 snRNP via protein-protein interactions.

PRPF8 SNRNP200

1.00e-05629210788320
Pubmed

Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk.

LYN EGFR

1.00e-0562928657103
Pubmed

Tumor suppressor RBM5 directly interacts with the DExD/H-box protein DHX15 and stimulates its helicase activity.

PRPF8 SNRNP200

1.00e-05629222569250
Pubmed

Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer.

CCND1 EGFR

1.00e-05629220418097
Pubmed

Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway.

CCND1 EGFR

1.00e-05629215950906
Pubmed

Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.

CCND1 EGFR

1.00e-05629216788380
Pubmed

Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways.

LYN EGFR

1.00e-0562927782294
Pubmed

Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.

LYN EGFR

1.00e-0562929890970
Pubmed

A Hypoxia-Induced SCFFBXL1 E3 Ligase Ubiquitinates and Degrades the MEN1 Tumor Suppressor to Promote Colorectal Cancer Tumorigenesis.

CCND1 SSTR2 KIF24

1.33e-055529334237211
Pubmed

Tyrosine residues in bovine phospholipase C-gamma phosphorylated by the epidermal growth factor receptor in vitro.

LYN EGFR

1.41e-0572921689310
Pubmed

RGS16 function is regulated by epidermal growth factor receptor-mediated tyrosine phosphorylation.

LYN EGFR

1.41e-05729211602604
Pubmed

Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers.

LYN EGFR

1.41e-05729223764002
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

LIFR RRP15 CCND1 DNAJC10 PRPF8 AIFM1 SNRNP200 RAB27A

1.67e-05144029830833792
Pubmed

Study on the different expression of molecular markers between cardiac cancer and distal gastric cancer and their correlations with clinicopathological features.

CCND1 EGFR

1.87e-05829219923826
Pubmed

Identification of a new adapter protein that may link the common beta subunit of the receptor for granulocyte/macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 to phosphatidylinositol 3-kinase.

LYN EGFR

1.87e-0582927499252
Pubmed

Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling.

LYN EGFR

1.87e-0582928885868
Pubmed

A kinase-independent role for EGF receptor in autophagy initiation.

ATG14 EGFR

1.87e-05829225594178
Pubmed

Death by splicing: tumor suppressor RBM5 freezes splice-site pairing.

PRPF8 SNRNP200

1.87e-05829218951082
Pubmed

Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2.

LYN EGFR

1.87e-05829220534535
Pubmed

Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415).

CCND1 EGFR

1.87e-05829220631636
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

LIFR PASK RRP15 DNAJC10 PRPF8 EGFR AIFM1 SNRNP200

2.10e-05148729833957083
Pubmed

EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance.

ATG14 EGFR

2.41e-05929224034250
Pubmed

In vitro tyrosine phosphorylation of PLC-gamma 1 and PLC-gamma 2 by src-family protein tyrosine kinases.

LYN EGFR

2.41e-0592927682059
Pubmed

Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells.

LYN EGFR

2.41e-05929223866081
Pubmed

Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.

CCND1 LYN

3.01e-051029217254966
Pubmed

Structure of a human catalytic step I spliceosome.

PRPF8 SNRNP200

3.01e-051029229301961
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

RRP15 ATG14 DNAJC10 PRPF8 AIFM1 SNRNP200

3.28e-0575929635915203
Pubmed

The nuclear cap-binding complex interacts with the U4/U6·U5 tri-snRNP and promotes spliceosome assembly in mammalian cells.

PRPF8 SNRNP200

4.41e-051229223793891
Pubmed

Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: an immediate source for thousands of new mouse models.

LYN RAB27A

5.21e-051329222724066
Pubmed

Loss of apoptosis-inducing factor results in cell-type-specific neurogenesis defects.

CCND1 AIFM1

5.21e-051329218463247
Pubmed

The network of protein-protein interactions within the human U4/U6.U5 tri-snRNP.

PRPF8 SNRNP200

5.21e-051329216723661
Pubmed

Human U4/U6.U5 and U4atac/U6atac.U5 tri-snRNPs exhibit similar protein compositions.

PRPF8 SNRNP200

6.07e-051429211971955
Pubmed

Large-scale mapping of human protein-protein interactions by mass spectrometry.

PASK RRP15 LRRK1 PRPF8 LYN AIFM1 SNRNP200

7.03e-05128429717353931
Pubmed

Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice.

CCND1 EGFR

8.00e-051629230979723
Pubmed

BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing.

PRPF8 SNRNP200

1.14e-041929225263594
Pubmed

Defects of pelage hairs in 20 mouse mutations.

EGFR AIFM1

1.26e-04202927738386
Pubmed

The TIP60 Complex Is a Conserved Coactivator of HIF1A.

PRPF8 AIFM1 SNRNP200

1.37e-0412029327320910
Pubmed

Specific Rab GTPase-activating proteins define the Shiga toxin and epidermal growth factor uptake pathways.

TBC1D10C EGFR

1.40e-042129217562788
Pubmed

Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA.

AIFM1 SNRNP200

1.40e-042129226582913
Pubmed

Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.

ZNF462 DNAJC10 HOMEZ

1.55e-0412529332891193
Pubmed

Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.

RRP15 PRPF8 LYN SNRNP200

1.64e-0433429430425250
Pubmed

Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA).

LYN EGFR

1.68e-042329216799092
Pubmed

A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.

PRPF8 SNRNP200

1.83e-042429233705438
Pubmed

Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice.

CCND1 AIFM1

1.83e-042429219139267
Pubmed

Stage-specific control of neural crest stem cell proliferation by the small rho GTPases Cdc42 and Rac1.

CCND1 EGFR

1.83e-042429219265663
Pubmed

The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85.

LYN AIFM1

1.83e-042429221822214
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

RRP15 DNAJC10 PRPF8 AIFM1 SNRNP200

1.91e-0465529535819319
InteractionRIMS2 interactions

LYN EGFR RAB27A

7.66e-0627293int:RIMS2
InteractionECD interactions

PRPF8 EGFR SNRNP200 RAB27A

2.29e-05117294int:ECD
InteractionMATK interactions

LRRK1 LYN EGFR

3.18e-0543293int:MATK
InteractionMAP4K1 interactions

LRRK1 DNAJC10 LYN EGFR

3.46e-05130294int:MAP4K1
InteractionPRPF4 interactions

LIFR PRPF8 LYN EGFR SNRNP200

3.86e-05271295int:PRPF4
InteractionPPP5C interactions

DLGAP2 LRRK1 PRPF8 EGFR SNRNP200

3.93e-05272295int:PPP5C
InteractionPTPN6 interactions

LIFR RRP15 SSTR2 LYN EGFR

4.36e-05278295int:PTPN6
InteractionBLNK interactions

LYN EGFR AIFM1

4.44e-0548293int:BLNK
InteractionFBXO6 interactions

LIFR DNAJC10 PRPF8 EGFR AIFM1 SNRNP200 RAB27A

5.52e-05717297int:FBXO6
InteractionSHANK2 interactions

DLGAP2 SSTR2 EGFR

6.68e-0555293int:SHANK2
InteractionDOK3 interactions

LRRK1 LYN EGFR

7.44e-0557293int:DOK3
InteractionPDCD7 interactions

EGFR SNRNP200 METAP2

8.25e-0559293int:PDCD7
InteractionFSAF1 interactions

PRPF8 EGFR SNRNP200

8.68e-0560293int:FSAF1
InteractionCHAF1A interactions

ATG14 PRPF8 EGFR AIFM1 SNRNP200

8.75e-05322295int:CHAF1A
InteractionPTPN18 interactions

PASK EGFR AIFM1

9.12e-0561293int:PTPN18
InteractionCYP4V2 interactions

LYN EGFR

1.09e-0411292int:CYP4V2
InteractionLSM4 interactions

PRPF8 EGFR SNRNP200 HOMEZ

1.18e-04178294int:LSM4
InteractionEIF3M interactions

PRPF8 EGFR METAP2 RAB27A

1.28e-04182294int:EIF3M
InteractionSNRPG interactions

PRPF8 EGFR SNRNP200 METAP2

1.77e-04198294int:SNRPG
InteractionUSP39 interactions

PRPF8 EGFR SNRNP200 RAB27A

1.88e-04201294int:USP39
InteractionDNA2 interactions

PASK LYN EGFR

1.97e-0479293int:DNA2
InteractionPOLDIP2 interactions

DNAJC10 PRPF8 EGFR AIFM1

2.18e-04209294int:POLDIP2
InteractionGPBP1L1 interactions

LRRK1 SNRNP200 METAP2

2.53e-0486293int:GPBP1L1
InteractionPRCC interactions

DNAJC10 PRPF8 EGFR

2.53e-0486293int:PRCC
InteractionRGS16 interactions

LYN EGFR

2.68e-0417292int:RGS16
InteractionRAB27A interactions

PRPF8 SNRNP200 RAB27A

2.71e-0488293int:RAB27A
InteractionPIK3R1 interactions

PASK SSTR2 PRPF8 LYN EGFR

2.76e-04412295int:PIK3R1
InteractionTEC interactions

LRRK1 LYN EGFR

2.89e-0490293int:TEC
InteractionSMU1 interactions

CCND1 PRPF8 EGFR SNRNP200

2.98e-04227294int:SMU1
InteractionSERAC1 interactions

EGFR AIFM1

3.02e-0418292int:SERAC1
CytobandEnsembl 112 genes in cytogenetic band chr11q13

TBC1D10C CCND1 TPCN2

2.90e-03454293chr11q13
CytobandEnsembl 112 genes in cytogenetic band chr5p13

LIFR PDZD2

3.50e-03139292chr5p13
CoexpressionGSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP

PRKD3 CCND1 ERI2 PRPF8 LYN

2.52e-06200295M3675
ToppCellIPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class

LIFR TRABD2A EGFR PDZD2

7.02e-06192294e911e286da26202853f9650ba3cdefe5a5c9b585
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ZNF462 CCND1 TMEM236

1.13e-04145293f6ba6cf0c8d0ee87a7904485b27eb9261fcb6edd
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Tgfb1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ADGRF4 CCND1 SSTR2

1.13e-0414529384d50a13b48d50c16e768422908e371a55972d0e
ToppCell5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRKD3 DNAJC10 SSTR2

1.40e-04156293203ef22eb76bd2b829b027c30af0557080f4006c
ToppCellsevere_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2)

ZNF462 PASK TRABD2A

1.45e-041582938ab3d8a9b7a1daa890d76dde1d6182af40b70021
ToppCellsevere_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2)

ZNF462 PASK TRABD2A

1.45e-04158293ff3fa4bd06e01363429aec4bb587b95819bf0fc9
ToppCellcellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TBC1D10C PASK TRABD2A

1.48e-04159293048b6a97568242c8846034277680632e5de75840
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TRABD2A LRRK1 SSTR2

1.59e-041632936ed2a71385e85508ed513282c06440add7cc010c
ToppCelldroplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RRP15 CCND1 TMEM236

1.65e-041652931c630f9ecde2e0243922a2be4b1ab5adcfcb0893
ToppCell10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4|Liver / Manually curated celltypes from each tissue

PASK DLGAP2 TRABD2A

1.71e-04167293ab6273ae5d76a3f9a05c58320e3dee80f9b99e47
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TRABD2A LRRK1 SSTR2

1.71e-041672935d89f5bcd0aaa772c1d09c2cc46fbfe0a90f9f12
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRKD3 LYN METAP2

1.74e-0416829308eb1284f9b8bd3e0e4b21bfc2bbee01d35a0bd7
ToppCelldroplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

1.77e-041692937962165cab84af73d20b56eb70b1ed87c94025ef
ToppCelldroplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RRP15 CCND1 TMEM236

1.80e-04170293545c755b057871b7a22221a049a63a61713dad1d
ToppCellfacs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

1.83e-041712936a0fafb8fd9fc7671618eeb2bf528ce8ce86b794
ToppCellfacs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

1.83e-04171293e02b5831768dbb1b68998b672e55c9680ab0cc86
ToppCelldroplet-Lung-nan-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RRP15 CCND1 TMEM236

1.83e-0417129306fe7eeffc6e0735342b88e1d1ae26a9b477fece
ToppCellmild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

TRABD2A CATSPERE SSTR2

1.83e-0417129378491478ba65bad45238fe114f5251b2adea323d
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

1.86e-041722937fb31ccbcd0204c3612986a6bc20d57ed6825e9c
ToppCell(07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition

RRP15 CCND1 LYN

1.86e-041722935776b638b845d054f6e884e7df0412477f48517d
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

1.86e-041722932a4614b3d25e8c6b095e6992d8ca35371dcdb5e1
ToppCelldroplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

1.86e-0417229330916a902c151907745756d14327e24adc34afef
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRKD3 LRRK1 DNAJC10

1.93e-04174293fde40c5d51f5380088360dc5a583eb04e518deb6
ToppCelldroplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

1.96e-0417529321bc0e59a9509d38751ce6aad2325f341bc70eff
ToppCell3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRKD3 DLGAP2 LYN

1.96e-0417529343be63976da5ad0764d24d90919a77ce46068f52
ToppCellfacs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.00e-0417629374f851a398c7562dd713bc0d8d488c0037243112
ToppCellfacs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.00e-0417629331b5459a978d5cdde0af03a77401e0464d8c95ba
ToppCell367C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

DLGAP2 TRABD2A LRRK1

2.03e-04177293a0ff337f11bdb11959ac71805ff94be6b4ec1083
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TRABD2A LRRK1 SSTR2

2.03e-041772937e799333307448c6a94d1f33dbc59c543336f45e
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TRABD2A LRRK1 SSTR2

2.06e-04178293a48739a588f361b4bc69405d7e256c11f61cf43c
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TRABD2A LRRK1 SSTR2

2.10e-04179293b35a7f8115c997c390201da01d7cb10b10769aec
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TRABD2A LRRK1 SSTR2

2.10e-04179293d3d3a9afaac28fa4f2c448c73d79bcbbbea088d7
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DLGAP2 EGFR PDZD2

2.10e-04179293a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCelldroplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.10e-04179293d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRRK1 SSTR2 HOMEZ

2.13e-04180293be10fe5bf7c3a671c42704ce7dd8226ab6896794
ToppCellfacs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.13e-04180293bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCellfacs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.13e-04180293839defb40f7cfb2711e9025194de636533f51bcd
ToppCellfacs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.13e-0418029382965ed1b72a1873c24dd4553d39681596057316
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRRK1 SSTR2 HOMEZ

2.13e-041802933b747a517ce75ef2ff09011c037dad7b01ed3e03
ToppCelldroplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.13e-04180293df60970520fba2ac0639faa54096766d07418ca4
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TBC1D10C LRRK1 LYN

2.13e-0418029365c069585737302a69b9a01476f4eb8b50cb2bfd
ToppCelldroplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.13e-0418029364f01494a4052186773720e10b4e7c724ff94547
ToppCellfacs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.17e-04181293e2481291c236105774c53883e6f20da11941df9b
ToppCellCOPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class

DLGAP2 TRABD2A LRRK1

2.17e-04181293675603a401d92cf9fdcd44e211ec899fa86a0d49
ToppCellfacs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR CCND1 EGFR

2.17e-04181293782716b8b1d447d2bbe09a693fa5ed7ebeac0efb
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DLGAP2 TRABD2A LRRK1

2.20e-0418229314a117c5e50db31ee1b2cf4df4d133451fd6d55f
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

LIFR EGFR PDZD2

2.24e-041832936847c1252d6bb105524f812658112517fd351eab
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TRABD2A LRRK1 SSTR2

2.27e-041842939cc5c588f7c6631b3fb8a522214a09ca32947e72
ToppCell10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD4_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TBC1D10C PASK TRABD2A

2.31e-0418529332f43ddc8a899827924834546db33928e353271b
ToppCellMild-CD4+_T|Mild / Disease group and Cell class

PASK DLGAP2 TRABD2A

2.31e-04185293c28ecb63146de1b02418e5a4fad0ae7c2b66a41d
ToppCellIPF-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class

DLGAP2 TRABD2A LRRK1

2.35e-04186293d0d3953d9b199e0e792990b8551efb993393fe7e
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF462 LIFR EGFR

2.35e-041862935c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCellControl-Myeloid-DC_Mature|Control / Disease state, Lineage and Cell class

DLGAP2 TRABD2A LRRK1

2.38e-04187293049780ca2a3e6adcd89dc2cf3095b5ad068b244a
ToppCellIPF-Myeloid-DC_Mature|IPF / Disease state, Lineage and Cell class

DLGAP2 TRABD2A LRRK1

2.38e-0418729363e0304a0183b69aebb0d1a4640a506a0d6fb6e9
ToppCellCOPD-Myeloid-DC_Mature|COPD / Disease state, Lineage and Cell class

DLGAP2 TRABD2A LRRK1

2.42e-04188293de93ccb53edb8599da9e312db0e3af604c21f673
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LRRK1 LYN METAP2

2.42e-041882939a10536afa2dea34c78421d36564cfd8252afe45
ToppCelldroplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZNF462 LIFR RAB27A

2.46e-041892938e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PRKD3 DNAJC10 LYN

2.46e-04189293b13f315f617840eb5143a4e8a33a657c20365c21
ToppCelldroplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZNF462 LIFR RAB27A

2.46e-04189293fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LRRK1 LYN TMEM236

2.50e-04190293788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCellE15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SSTR2 EGFR PDZD2

2.50e-0419029384fbd5664ec886120963d4f50dfa1fd1851d36c1
ToppCellCOPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class

LIFR EGFR PDZD2

2.54e-04191293ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LRRK1 LYN TMEM236

2.54e-04191293baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCellbackground-B_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

AMBP TBC1D10C LYN

2.54e-04191293a189fdc9c739bb0801e2f38af0932a1ea615cb34
ToppCell367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

DLGAP2 CCND1 LYN

2.58e-041922935f4f44f15d3a2846981e68296643a4634930a211
ToppCellFetal_29-31_weeks-Immune-T_lymphocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TBC1D10C PASK TRABD2A

2.58e-0419229392f141d5ac462f652f405efa73ac6ef751f40ea3
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

LIFR ADGRF4 EGFR

2.58e-041922938899d81306770adda893b5e146df1253971754c5
ToppCell367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

DLGAP2 CCND1 LYN

2.58e-041922935e709c0714e8eba27e03a6def0544256bedb3ced
ToppCellCOPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class

DLGAP2 TRABD2A LRRK1

2.58e-04192293baebd462f464e7d0e462d07a74bb5d685a9fc3b6
ToppCellFetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TBC1D10C PASK TRABD2A

2.58e-0419229369a2b04f03a1b82d067018379f7b8a116e954040
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

LIFR ADGRF4 EGFR

2.58e-041922935fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCellChildren_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DLGAP2 LRRK1 LYN

2.62e-0419329358e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TBC1D10C PASK TRABD2A

2.66e-041942934138f3e8aa214504fca03962a43250670ae45215
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK1 DNAJC10 LYN

2.66e-04194293ff661419b697aef51a53fdeac8d37d870d65f491
ToppCellcritical-Epithelial-IRC-IFNG_responsive_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LIFR ADGRF4 CCND1

2.66e-04194293568e1676a61063a5d858a43b86f8c2ad536505c2
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

LIFR CCND1 EGFR

2.66e-04194293b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TBC1D10C PASK TRABD2A

2.66e-04194293906fe1689906d1498acf6fd26a215c7e5a854a38
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TBC1D10C PASK TRABD2A

2.66e-04194293af7428582b96a500f255c45efc02b6c10c4740d9
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-Naive_CD4+_T|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

TBC1D10C PASK TRABD2A

2.66e-041942930b5db5f5ec99fc93dde28f0414cae1c2eba8001f
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRKD3 DNAJC10 METAP2

2.70e-04195293cccc9c70bb8f6df8c6ab94534c17475af1d3e224
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TBC1D10C LRRK1 LYN

2.70e-041952932d485373bfd9bb4bb9236bf0b31d03e132c8018f
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PRKD3 DNAJC10 LYN

2.70e-04195293481989d2e5bd2582da3d86b0155c4d6615317067
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PRKD3 DNAJC10 LYN

2.70e-041952936108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK1 DNAJC10 LYN

2.70e-041952936da69e3eba036936f44bc052996ad12b6309055e
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Tfh|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBC1D10C PASK RAB27A

2.70e-04195293b2ecab35db438c82872cd16a6e9f013475e559ef
ToppCellcellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TBC1D10C PASK TRABD2A

2.70e-04195293e17d05b9ef5e63b49385ddb2fbdc2ade9ea8723f
ToppCellmetastatic_Lymph_Node-T/NK_cells-Naive_CD4+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass

TBC1D10C PASK TRABD2A

2.70e-04195293c72943618ced6797202894f78fbb8f300c2e4387
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

LIFR CCND1 EGFR

2.70e-041952930e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCellcellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TBC1D10C PASK TRABD2A

2.70e-04195293120412817b5ef3293238a65903234b6d4ea8dd5c
ToppCelltumor_Lung-T/NK_cells-Naive_CD4+_T|tumor_Lung / Location, Cell class and cell subclass

TBC1D10C PASK TRABD2A

2.74e-04196293d5bab34992bf3ac08f20c07358f9745eff5b50d8
ToppCellTracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

TBC1D10C PASK TRABD2A

2.78e-041972931c78bd52b94a9466459a645ac9bd14bac22c54bd
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ZNF462 LIFR EGFR

2.78e-04197293b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ZNF462 LIFR EGFR

2.78e-041972935afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCellParenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

TBC1D10C PASK TRABD2A

2.78e-04197293e60deb009238702110c3b0948778802df215ad74
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ZNF462 LIFR EGFR

2.78e-041972931baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK1 DNAJC10 LYN

2.78e-04197293fa3cc33c975648172feabb485c3bdd087f1f8ea7
ToppCellcontrol-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TBC1D10C PASK TRABD2A

2.82e-04198293a2c70840c38e9a76543060c112e7d9332dd58a89
ToppCellBAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TBC1D10C PASK TRABD2A

2.82e-04198293fc8099bce80d84b29bdcc87064d4d8375dddfa0f
ToppCellwk_20-22-Hematologic_Lymphocytic-T_&_ILC-CD4_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

TBC1D10C PASK TRABD2A

2.82e-0419829351af4e53a7a4aa7fb84380e1f10229725a178a73
ToppCellCOVID-CD4|COVID / Condition, Cell_class and T cell subcluster

TBC1D10C PASK TRABD2A

2.82e-041982933b72d3fa96f8cda528c483afdff391385113080d
DrugAC1L1FWN

LIFR DLGAP2 CCND1 SSTR2 EGFR METAP2

3.61e-07227296CID000003425
DrugCanertinib

CCND1 EGFR AIFM1

4.06e-0712293ctd:C420268
DrugNVP-AEW541

CCND1 EGFR AIFM1

1.03e-0616293ctd:C501177
Drugmethyl 2,5-dihydroxycinnamate

PRKD3 LYN EGFR RAB27A

2.69e-0677294CID000003248
Drugbosutinib

CCND1 LYN EGFR

2.81e-0622293ctd:C471992
Drug0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A

LIFR DLGAP2 LYN SNRNP200 PDZD2

4.40e-061952953969_UP
Drugsaracatinib

CCND1 EGFR AIFM1

5.32e-0627293CID010302451
DrugBIM 23120

CCND1 SSTR2

1.56e-055292ctd:C519495
Drugbenzamide

LYN EGFR AIFM1

1.92e-0541293ctd:C037689
Drugtaiwanin C

CCND1 EGFR

2.34e-056292ctd:C467766
DrugKN 93

CCND1 EGFR AIFM1

2.72e-0546293ctd:C072105
Drug3-(2-(dimethylamino)isopropoxy)-1-hydroxybenzo(b)naphtho(2,3-d)furan-6,11-dione

CCND1 EGFR

3.28e-057292ctd:C560905
DrugPKI 166

CCND1 EGFR

3.28e-057292ctd:C410026
DrugAC1L3JHX

PRKD3 CCND1 SSTR2 EGFR

3.40e-05146294CID000090206
DrugAC1O745K

AMBP CCND1 EGFR

3.50e-0550293CID006518178
DrugMS-275

CCND1 EGFR AIFM1 METAP2

3.68e-05149294CID000004261
Drugursolic acid

CCND1 EGFR AIFM1

4.17e-0553293ctd:C005466
Drug5-(4-((6-(allyloxy)-2,5,7,8-tetramethylchroman-2-yl)methoxy)-3-methoxybenzylidene)thiazolidine-2,4-dione

CCND1 EGFR

4.37e-058292ctd:C513003
DrugAC1L1TXN

CCND1 METAP2 PDZD2

4.41e-0554293CID000060791
Drugsorafenib

CCND1 EGFR AIFM1 PDZD2

4.63e-05158294CID000216239
Drugdltp

EGFR METAP2 PDZD2

4.92e-0556293CID000031250
DrugBoc-D-FMK

CCND1 AIFM1

5.61e-059292ctd:C476029
Drug4'-methoxy-1-naphthylfenoterol

CCND1 EGFR

5.61e-059292ctd:C000603500
Drugtaxol

PRKD3 CCND1 EGFR AIFM1 METAP2 PDZD2

6.32e-05560296CID000004666
DrugAC1L1E22

CCND1 AIFM1 METAP2

6.68e-0562293CID000002607
DrugParthenolide [20554-84-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A

PASK RRP15 EGFR RAB27A

8.20e-051832945530_DN
DrugBP-1-102

CCND1 EGFR

8.55e-0511292ctd:C000595192
DrugAC1L2CUR

CCND1 EGFR

8.55e-0511292CID000018812
DrugSP600125

PRKD3 CCND1 EGFR AIFM1 PDZD2

8.57e-05362295CID000008515
DrugCID11987713

CCND1 EGFR AIFM1 METAP2

9.48e-05190294CID011987713
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA

PASK RRP15 METAP2 RAB27A

9.48e-051902941077_DN
DrugVelcade (bortezomib

CCND1 DNAJC10 EGFR AIFM1 METAP2

9.99e-05374295CID000093860
Drugalvocidib

CCND1 LYN AIFM1

1.00e-0471293ctd:C077990
DrugWP 744

CCND1 AIFM1

1.03e-0412292ctd:C451735
DrugAC1L28C4

CCND1 EGFR

1.03e-0412292CID000042675
DrugFluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A

PASK RRP15 EGFR RAB27A

1.07e-041962947234_DN
DrugProadifen hydrochloride [62-68-0]; Down 200; 10.2uM; PC3; HT_HG-U133A

PRKD3 LYN METAP2 PDZD2

1.11e-041982945807_DN
DrugCinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A

PASK LYN EGFR RAB27A

1.11e-041982946257_UP
Drugcelecoxib; Down 200; 10uM; MCF7; HG-U133A

PRKD3 PASK SSTR2 LYN

1.11e-04198294252_DN
DrugArecoline hydrobromide [300-08-3]; Down 200; 17uM; PC3; HT_HG-U133A

LIFR PASK LYN EGFR

1.13e-041992946322_DN
Drug3-epi-betulinic acid

CCND1 EGFR AIFM1

1.13e-0474293CID000002371
DrugAC1L45LU

CCND1 EGFR AIFM1 METAP2

1.27e-04205294CID000151069
Drugflavopiridol

CCND1 EGFR AIFM1 METAP2

1.55e-04216294CID005287969
DrugHS-1199

CCND1 AIFM1

1.63e-0415292ctd:C503536
Drugarylsulfate

AMBP AIFM1

1.63e-0415292CID000074426
DrugK00077

PRKD3 LIFR LYN EGFR

1.67e-04220294CID006419759
DrugPiperonyl Butoxide

LIFR PASK CCND1 PRPF8 EGFR

1.78e-04423295ctd:D010882
Drugmelanin

TPCN2 PRPF8 AIFM1 RAB27A

1.88e-04227294CID006325610
Drugimatinib

LIFR CCND1 LYN EGFR AIFM1

1.92e-04430295CID000005291
DrugGold

CCND1 DNAJC10 EGFR AIFM1 METAP2

1.96e-04432295ctd:D006046
DrugAG213

PRKD3 LYN EGFR

1.96e-0489293CID005328803
Drugorthovanadate

PRKD3 CCND1 SSTR2 EGFR AIFM1

2.02e-04435295CID000061672
DrugAC1L1WZD

CCND1 AIFM1

2.11e-0417292CID000062368
Drugrubitecan

CCND1 AIFM1

2.11e-0417292ctd:C079905
Drug6-O-angeloylenolin

CCND1 AIFM1

2.11e-0417292ctd:C531937
DrugAC1NUZ8M

CCND1 TPCN2 AIFM1

2.16e-0492293CID000073211
Drugcadmium

PRKD3 AMBP TPCN2 EGFR AIFM1

2.20e-04443295CID000002514
DrugHydrochloric Acid

CCND1 SSTR2 EGFR

2.30e-0494293ctd:D006851
DrugHistamine

AMBP CCND1 EGFR

2.60e-0498293ctd:D006632
DrugTAPP-Br

PRKD3 EGFR

2.64e-0419292CID000160326
DrugHS 1200

CCND1 AIFM1

2.64e-0419292ctd:C479128
Drugaminoflavone

AMBP EGFR

2.93e-0420292CID000389710
DrugCL-387,785

CCND1 EGFR

2.93e-0420292CID000002776
DrugStarch

LIFR CCND1

2.93e-0420292ctd:D013213
Drug6)-gingerol

CCND1 EGFR

3.24e-0421292CID000090942
DrugCoumarins

CCND1 AIFM1

3.24e-0421292ctd:D003374
DrugMethylnitronitrosoguanidine

AMBP CCND1 EGFR AIFM1

3.39e-04265294ctd:D008769
Drugloxtidine

AMBP SSTR2

3.56e-0422292CID000055472
DrugN1-aminopropylagmatine

SSTR2 EGFR

3.56e-0422292CID000541551
Drugborane

CCND1 EGFR AIFM1 METAP2

3.59e-04269294CID000006331
DrugNSC226080

PRKD3 LIFR CCND1 EGFR AIFM1 METAP2

3.89e-04782296CID000005040
DrugNSC 680410

CCND1 AIFM1

3.90e-0423292ctd:C404397
Drugsodium;isothiocyanate

PRPF8 SNRNP200

3.90e-0423292CID010953423
DrugPHA665752

CCND1 EGFR

3.90e-0423292CID010461815
DrugAG 1879

CCND1 LYN EGFR

3.96e-04113293ctd:C412373
Drug4-epidoxorubicin

PRKD3 CCND1 DNAJC10 EGFR AIFM1 METAP2

4.05e-04788296CID000001690
DrugGX015-070

EGFR AIFM1

4.25e-0424292CID011244031
DrugEGFR inhibitor

CCND1 EGFR PDZD2

4.72e-04120293CID009549299
DrugBIBX1382BS

CCND1 EGFR

5.00e-0426292CID006918508
DrugPhIP-HCl

AMBP CCND1 PDZD2

5.07e-04123293CID000001530
DrugHydroxamic Acids

CCND1 EGFR

5.39e-0427292ctd:D006877
Drug6-bromoindirubin-3'-oxime

CCND1 AIFM1

5.39e-0427292ctd:C483321
Drugdichloromethanediamine

PRKD3 AMBP CCND1 EGFR AIFM1

5.42e-04539295CID005311048
DrugAC1L1DKK

PRKD3 CCND1 EGFR

5.57e-04127293CID000002390
DrugAC1L1JM9

PRKD3 LYN EGFR AIFM1

5.69e-04304294CID000005103
DrugDiazoxide

CCND1 AIFM1

5.80e-0428292ctd:D003981
Drugselva

LYN EGFR

5.80e-0428292CID000010157
DrugMethoxychlor

PASK CCND1 SSTR2 EGFR RAB27A

5.89e-04549295ctd:D008731
Drugvanadyl

PRKD3 SSTR2 LYN EGFR

5.90e-04307294CID000061671
DrugPD 169316

EGFR AIFM1

6.23e-0429292ctd:C408604
DrugAnilino

EGFR METAP2

6.23e-0429292CID000137550
Drugamiloride

PRKD3 AMBP TPCN2 EGFR

6.50e-04315294CID000016230
Drug2,4-xylidinothiazoline

AMBP RAB27A

6.67e-0430292CID000099296
DrugTt 232

SSTR2 EGFR

6.67e-0430292CID000164469
DrugAC1L9JKX

AMBP AIFM1

6.67e-0430292CID000446363
Drugdeguelin

CCND1 EGFR AIFM1

6.94e-04137293ctd:C107676
Drugchlorophyllin

CCND1 AIFM1

7.12e-0431292CID000123798
Drugthallium iodide

AMBP CCND1

7.12e-0431292CID000062679
DrugIN1434

LYN EGFR

7.12e-0431292CID000002059
DrugAc-DEVD-cmk

CCND1 AIFM1

7.12e-0431292CID009959259
Diseasebronchiolo-alveolar adenocarcinoma (is_marker_for)

CCND1 EGFR

5.20e-064282DOID:4926 (is_marker_for)
DiseasePapilloma

CCND1 EGFR

5.70e-0512282C0030354
DiseasePapillomatosis

CCND1 EGFR

5.70e-0512282C0205875
DiseasePapilloma, Squamous Cell

CCND1 EGFR

5.70e-0512282C0205874
Diseaseglioma

EGFR RAB27A

1.98e-0422282EFO_0005543
Diseasemelanoma

DLGAP2 CCND1 RAB27A

2.30e-04126283EFO_0000756
DiseaseMalignant Neoplasms

CCND1 DNAJC10 EGFR

2.41e-04128283C0006826
Diseaseretinitis pigmentosa (implicated_via_orthology)

PRPF8 SNRNP200

3.00e-0427282DOID:10584 (implicated_via_orthology)
Diseaseintestinal cancer (implicated_via_orthology)

LYN EGFR

4.23e-0432282DOID:10155 (implicated_via_orthology)
Diseaseprostate cancer (implicated_via_orthology)

CCND1 PRPF8

4.50e-0433282DOID:10283 (implicated_via_orthology)
DiseaseColorectal Carcinoma

LIFR CCND1 ERI2 EGFR SNRNP200

4.69e-04702285C0009402
Diseasecervical cancer

CCND1 EGFR

4.78e-0434282C4048328
DiseaseParkinsonism (biomarker_via_orthology)

LYN EGFR

4.78e-0434282DOID:0080855 (biomarker_via_orthology)
DiseaseUterine Cervical Neoplasm

CCND1 EGFR

5.07e-0435282C0007873
DiseaseMalignant neoplasm of brain

CCND1 EGFR

5.98e-0438282C0153633
DiseaseBrain Neoplasms

CCND1 EGFR

6.30e-0439282C0006118
Diseaseretinitis pigmentosa (is_implicated_in)

PRPF8 SNRNP200

6.96e-0441282DOID:10584 (is_implicated_in)
DiseaseCarcinoma, Transitional Cell

AMBP CCND1

6.96e-0441282C0007138
Diseasehigh grade glioma (is_marker_for)

CCND1 EGFR

7.30e-0442282DOID:3070 (is_marker_for)
Diseaselung adenocarcinoma (is_implicated_in)

CCND1 EGFR

9.93e-0449282DOID:3910 (is_implicated_in)
DiseaseSquamous cell carcinoma of the head and neck

CCND1 EGFR

1.12e-0352282C1168401
Diseasetransitional cell carcinoma (is_marker_for)

CCND1 EGFR

1.64e-0363282DOID:2671 (is_marker_for)
Diseasecarcinoma (implicated_via_orthology)

LYN EGFR

1.69e-0364282DOID:305 (implicated_via_orthology)
DiseaseEndometrial Carcinoma

CCND1 EGFR

2.13e-0372282C0476089
DiseaseRetinitis pigmentosa

PRPF8 SNRNP200

2.25e-0374282cv:C0035334
DiseaseEsophageal Neoplasms

CCND1 EGFR

2.49e-0378282C0014859
DiseaseMalignant neoplasm of esophagus

CCND1 EGFR

2.49e-0378282C0546837
DiseaseProstatic Neoplasms

LIFR CCND1 DNAJC10 EGFR

2.59e-03616284C0033578

Protein segments in the cluster

PeptideGeneStartEntry
STCPWLKKIMDRMTV

AMBP

51

P02760
AWKMIRDGCVMKITR

ERI2

226

A8K979
MRRGTWRIVVPMTKD

CATSPERE

176

Q5SY80
TDQLRWKIMSCKMRI

ATG14

106

Q6ZNE5
WTMEKVRREGVKVMP

AIFM1

351

O95831
KRRWDEKACQMMLDI

ADGRF4

356

Q8IZF3
AETKRMEGWCKEMER

DLGAP2

876

Q9P1A6
MRKIVATWMLEVCEE

CCND1

56

P24385
IMKRMERCVDKSWIP

RAB27A

181

P51159
RSGEKIPVSVWMKRM

PASK

206

Q96RG2
WIKPGMTMIEICEKL

METAP2

186

P50579
QALMMECWDTKPEKR

LRRK1

1496

Q38SD2
KMIARRPIMAWFKEI

PDZD2

1791

O15018
NPWTEMEKIRVCVRK

KIF24

216

Q5T7B8
RPIWMEKMVMCRVKV

PRKD3

256

O94806
IMVKCWMIDADSRPK

EGFR

946

P00533
MKMCWKEKAEERPTF

LYN

476

P07948
MEKVKTWFMAQRLRC

HOMEZ

96

Q8IX15
CQVLMPEWKRMARTL

DNAJC10

591

Q8IXB1
VCLKRPSWMVDNKRM

LIFR

6

P42702
AKWRRPRTAKMITMA

SSTR2

151

P30874
KKCWPRDARMRLMKH

PRPF8

1131

Q6P2Q9
PADLIRQREMKWVEM

TBC1D10C

56

Q8IV04
ERKRPVWVMLMVNSL

TRABD2A

161

Q86V40
RDKRLEWEMMCRVKP

RRP15

136

Q9Y3B9
KMIDKRMWQSMCPLR

SNRNP200

1116

O75643
QTPRRERWCDHMMKK

ZNF462

251

Q96JM2
RKIKGWRPVLMMCVV

TMEM236

81

Q5W0B7
MMKKTLKCIRWSLPE

TPCN2

201

Q8NHX9